Yellow Card, a leading global stablecoin infrastructure provider, today announced the successful closing of a $40 million strategic funding round, with investment from SC Ventures by Standard Chartered, Sony Innovation Fund, Polychain Capital, Blockchain Capital, and additional strategic investors. The funding will scale Global USD Accounts, Yellow Card's end-to-end dollar account for businesses, and expand the stablecoin rails connecting it to markets worldwide. This brings Yellow Card's total...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal...
Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individua...
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relat...
Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has announced TXZ+™ Family Entry-Class M4V Group, standard microcontrollers[1] featuring an Arm® Cortex®-M4 core with a floating-point unit (FPU), that enhance security and data management in IoT devices and industrial equipment. Engineering samples are available. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805166440/en/Toshiba: TXZ+™ Family Entry-Class M4V Group...
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho...
NIQ (NYSE: NIQ) today launches its new EU5 FMCG Inflation Barometer - a monthly tracker across five Western Europe markets – France, Great Britain, Germany, Italy and Spain – designed to help retailers, manufacturers and the media understand how inflation is evolving across Europe’s largest grocery markets and how shoppers are responding. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806579111/en/EU5 CPG Inflation slows to +1.1%...
The global tablet market entered an expected period of decline in Q2 2026, with shipments falling 10% year on year to 36 million units, according to the latest research from Omdia. For the first time in years, tablet shipments also defied the typical seasonal pattern of sequentially higher Q2 shipments driven by back-to-school demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806999460/en/Worldwide tablet shipments 4Q23 - 2Q...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-resistant depression (TRD) in veterans, including those with concurrent post-traumatic stress disorder (PTSD). The tr...